Cannabis cultivation has, quite rightly, drawn the attention of growers to the presence of biological agents. Insects, fungi, and bacteria are natural enemies that threaten the harvest. However, there is a common confusion between economic damage to the producer and health risks to the end consumer. This article aims to clarify this crucial distinction, which is especially relevant in the context of therapeutic cannabis.
In brief
- Key distinction: The presence of fungi or bacteria does not imply automatic toxicity; many food processes depend on beneficial microorganisms.
- Common vs. real risks: Powdery mildew and gray mold affect product quality but lack evidence of direct human pathogenicity at typical doses.
- Specific danger: The fungus Aspergillus produces mycotoxins that pose a real risk, primarily to people with weakened immune systems.
- Hygiene and regulation: Cannabis legalization must include strict microbiological controls similar to those for other staple foods.
Microbial presence is not synonymous with danger
Before delving into pathology, it is essential to establish a basic principle: the fact that a plant or food contains bacteria or fungi does not automatically make it toxic. Nature is populated by microorganisms that are essential for human life.
Consider everyday examples: lactic fermentation, responsible for transforming milk into yogurt, depends on Bacillus bulgaricus and Lactobacillus. Similarly, bread, wine, miso, and soy sauce are products of microbial metabolism. Even blue-veined cheeses like Roquefort or Cabrales contain fungi that, in their controlled context, do not harm the consumer.
Therefore, we must avoid falling into unfounded alarmism upon the mere detection of a living organism in a sample. The problem arises only when certain microorganisms produce toxins or invade human tissues with pathogenic capacity.
Common fungi: Cultivation pests, not necessarily human enemies
In the realm of cannabis, two fungal diseases dominate growers’ concerns: powdery mildew (caused by Sphaerotheca macularis) and gray mold (Botrytis cinerea). Both are devastating to the harvest, ruining the aesthetic and chemical quality of the product.
However, unlike other plant-based foods such as grains or fruits, there is no solid scientific evidence linking these specific fungi to diseases in healthy humans. Their primary impact is economic: they reduce the yield and potency of the cannabis. Treatments to eradicate them usually focus on protecting the harvest rather than ensuring extreme biological safety for the end user.
The paradigmatic case: Aspergillus
This is where the distinction between risk and myth becomes critical. The Aspergillus family of fungi, which includes more than 600 species, presents a very different risk profile.
Mechanisms of infection:
- Direct invasion: The fungus can penetrate respiratory tissues (lungs, sinuses) and cause invasive aspergillosis. This is especially dangerous for people with immunodeficiencies.
- Mycotoxin production: Some strains generate toxic compounds that can affect the liver or kidneys, although the respiratory route is usually the main point of entry in the case of inhaled consumption.
Medical literature documents cases of pulmonary aspergillosis and sinusitis in cannabis smokers. It is important to contextualize these findings: Aspergillus infections are much more frequent in immunocompromised patients (due to HIV/AIDS, chemotherapy, or transplants) than in the general population. In many cases, cannabis use may be a therapeutic response to these conditions, creating a scenario where the risk of the biological contaminant overlaps with the medical need to consume cannabinoids.
Therefore, prudence requires extreme hygienic precautions in cultivation and processing when the product is intended for vulnerable patients. However, it is vital not to stigmatize cannabis as such; the risk lies in the presence of the specific pathogen (Aspergillus) and not in the plant per se.
Pathogenic bacteria: Salmonella and E. coli
Although less frequent than fungal diseases, there are records of serious bacterial contamination in cannabis samples. Salmonella spp., E. coli, or Klebsiella pneumoniae have been detected in research and have caused outbreaks of illness.
These cases are usually associated with poor cultivation practices, inadequate handling, or fecal contamination (for example, in hashish extraction processes with poor hygiene). Unlike gray mold, which is a cosmetic and agronomic problem, the presence of intestinal bacteria indicates a lack of basic sanitary control.
Risk reduction: Prudence and control
Given these facts, what is the appropriate approach from Psiconáutica?
- Risk assessment: Recognize that common fungi (powdery mildew) are low-risk to human health, while Aspergillus and fecal bacteria require immediate attention.
- Cultivation hygiene: Maintaining optimal environmental conditions (controlled humidity, adequate ventilation) prevents both pests and opportunistic pathogens.
- Responsible therapeutic use: Immunocompromised patients should consume cannabis products from sources that guarantee rigorous microbiological analysis. One should not assume safety without verifying the batch.
It is essential not to promise cures or minimize risks, but also not to fall into paralyzing fear at the sight of any detected microorganism. Science allows us to act with precision: control what is dangerous and accept what is harmless or of negligible risk.
Editorial closing
Cannabis regulation cannot be a mere administrative formality; it must be based on scientific evidence to protect public health. The normalization of this plant requires applying the same hygienic-sanitary standards as those applied to other staple foods.
As health professionals and educators, our role is to foster a culture of informed consumption. Understanding what a microbiological analysis means, knowing how to differentiate between a cosmetic fungus and a pathogenic one, and demanding transparency in production processes are essential steps toward advancing a sustainable and safe model.
Psiconáutica not only studies the mind but also the chemical and biological environment that surrounds us. Knowing the real risks of psychoactive substances is the first step toward exercising responsible autonomy over our own physical and mental well-being.
